Plain-English translation of NCT05973838 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to help people with opioid addiction stay in treatment, especially when they're also using other substances. The study uses peer recovery specialists — people who have lived experience with addiction and recovery — to deliver a behavioral activation program. This program helps people find positive activities and reasons to stay engaged with their buprenorphine treatment through a telemedicine clinic.
Many people struggle to stay in addiction treatment, and this challenge is especially tough in rural and underserved areas where treatment options are limited. This medication works best when people stick with it consistently, but co-occurring use of other drugs can make that harder. The researchers want to see if peer support combined with behavioral activation can help more people stay in care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to one of two groups. One group will work with a peer recovery specialist who uses behavioral activation techniques to help you find positive activities and stay engaged in treatment. The other group will receive standard support, including referrals to community resources and regular peer support. Both groups will continue receiving their regular buprenorphine treatment and visits with an addiction medicine doctor. The study involves about 160 participants total, and you'll have regular check-ins to see how you're doing.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States